Monthly Archives: July 2015

Delivery mortality and complications higher in epileptic women

Pregnant women with a history of epilepsy are at increased risk for death and complications during delivery, according to a new study. It is estimated that women with a history of epilepsy comprise… …read more

New Mutation Associated With Severe Obesity

A mutation newly identified in a morbidly obese individual shuts down production of an enzyme known to affect insulin production and appetite suppression, as well as other hormones. Medscape Medical News …read more

Cell-Free Fetal DNA Testing Warrants Caution, Committee Says

The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine issued a joint opinion on the appropriate use of cell-free fetal DNA screening. Medscape Medical News …read more

Cardiovascular disease in females — new perspectives on lifelong risks

While heart disease is the number one cause of death in both sexes, it poses special considerations in women–with risks often beginning in childhood and changing at different stages of life. …read more

Two new studies on the connection between hypertension and cognitive decline

With the number of individuals affected by cognitive decline expected to rise over the next few decades, investigating its potential causes is of major public health interest. …read more

Health information causing new mums anxiety

Pregnancy and motherhood are both wonderful and worrisome times – could public health campaigns and social stereotypes be contributing to anxiety for mothers? …read more

Review shows D&C raises preterm birth risk

LISBON – Dilation and curettage increases the risk for prematurity in subsequent pregnancy, according to a systematic review and meta-analysis of nearly 2 million women. Overall, D&C for… …read more

Expectant management holds its own in incomplete misoprostol miscarriage

LISBON – Expectant management is a safe and effective treatment for incomplete miscarriage after misoprostol, results of the MisoREST trial show. “Because it is non-invasive, we think it should be… …read more

Age drives miscarriage risk in RA patients

LISBON – Advanced age appears to trump disease activity or antirheumatic drug treatment as the driving force behind miscarriage in women with rheumatoid arthritis. “The risk for miscarriage in… …read more

FDA Oks Second Test to See if Essure Contraceptive Is Placed Right

Bayer Healthcare said on Wednesday the U.S. Food and Drug Administration approved using transvaginal ultrasound as an alternate test to confirm if the company’s Essure permanent birth control device has been placed properly. Reuters Health Information …read more